Bone drug Zometa does not help most with early or mid-stage breast cancer: study

SAN ANTONIO - One of the most promising new approaches for fighting breast cancer took a stunning setback Thursday when a major study showed that a bone-building drug did not stop cancer from returning or extend life for most women fighting the disease....More